vs
Side-by-side financial comparison of Twin Hospitality Group Inc. (TWNP) and Twist Bioscience Corp (TWST). Click either name above to swap in a different company.
Twist Bioscience Corp is the larger business by last-quarter revenue ($103.7M vs $82.3M, roughly 1.3× Twin Hospitality Group Inc.). Twist Bioscience Corp runs the higher net margin — -29.4% vs -29.7%, a 0.3% gap on every dollar of revenue. Twin Hospitality Group Inc. produced more free cash flow last quarter ($-7.4M vs $-34.8M).
Target Hospitality is a company that provides workforce lodging and other temporary, modular housing used for oil, gas and mining operations; large-scale events; and disaster relief. Target Hospitality is based in The Woodlands, Texas, and also has offices in Williston, North Dakota; Denver, Colorado; Calgary, Alberta.
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
TWNP vs TWST — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $82.3M | $103.7M |
| Net Profit | $-24.5M | $-30.5M |
| Gross Margin | — | 52.0% |
| Operating Margin | -16.2% | -31.7% |
| Net Margin | -29.7% | -29.4% |
| Revenue YoY | — | 16.9% |
| Net Profit YoY | — | 3.4% |
| EPS (diluted) | $-0.43 | $-0.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $103.7M | ||
| Q3 25 | $82.3M | — | ||
| Q2 25 | $87.8M | — | ||
| Q1 25 | $87.1M | — |
| Q4 25 | — | $-30.5M | ||
| Q3 25 | $-24.5M | — | ||
| Q2 25 | $-20.8M | — | ||
| Q1 25 | $-12.1M | — |
| Q4 25 | — | 52.0% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — |
| Q4 25 | — | -31.7% | ||
| Q3 25 | -16.2% | — | ||
| Q2 25 | -13.2% | — | ||
| Q1 25 | -1.2% | — |
| Q4 25 | — | -29.4% | ||
| Q3 25 | -29.7% | — | ||
| Q2 25 | -23.7% | — | ||
| Q1 25 | -13.9% | — |
| Q4 25 | — | $-0.50 | ||
| Q3 25 | $-0.43 | — | ||
| Q2 25 | $-0.38 | — | ||
| Q1 25 | $-0.26 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $197.9M |
| Total DebtLower is stronger | $402.8M | — |
| Stockholders' EquityBook value | $-92.1M | $456.1M |
| Total Assets | $516.8M | $638.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $197.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $402.8M | — | ||
| Q2 25 | $411.3M | — | ||
| Q1 25 | $413.0M | — |
| Q4 25 | — | $456.1M | ||
| Q3 25 | $-92.1M | — | ||
| Q2 25 | $-78.6M | — | ||
| Q1 25 | $-101.9M | — |
| Q4 25 | — | $638.1M | ||
| Q3 25 | $516.8M | — | ||
| Q2 25 | $535.1M | — | ||
| Q1 25 | $544.2M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-5.9M | $-24.8M |
| Free Cash FlowOCF − Capex | $-7.4M | $-34.8M |
| FCF MarginFCF / Revenue | -9.0% | -33.5% |
| Capex IntensityCapex / Revenue | 1.9% | 9.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-24.8M | ||
| Q3 25 | $-5.9M | — | ||
| Q2 25 | $-8.8M | — | ||
| Q1 25 | $-5.7M | — |
| Q4 25 | — | $-34.8M | ||
| Q3 25 | $-7.4M | — | ||
| Q2 25 | $-10.6M | — | ||
| Q1 25 | $-9.7M | — |
| Q4 25 | — | -33.5% | ||
| Q3 25 | -9.0% | — | ||
| Q2 25 | -12.1% | — | ||
| Q1 25 | -11.2% | — |
| Q4 25 | — | 9.6% | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 4.6% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
TWNP
Segment breakdown not available.
TWST
| Industrial Chemicals | $37.2M | 36% |
| Diagnostics | $35.3M | 34% |
| Food Or Agriculture | $12.8M | 12% |
| Academic Research | $12.2M | 12% |
| Health Care | $6.1M | 6% |
